Immunovant, Inc. Banner Image

Immunovant, Inc.

  • Ticker IMVT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Immunovant, Inc. Logo Image
  • 51-200 Employees
  • Based in New York City, New York
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.
5.0 / 5.0 (1)

Immunovant, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Immunovant, Inc.

Most Recent Annual Report

Immunovant, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Immunovant, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!